Empowering Pharmacists, Enabling Track and Trace

MeCure Industries PLC Pharmacist Loyalty Program Terms and Conditions

  • Eligibility: The MeCure Industries PLC Pharmacist Loyalty Program ("Program") is open to registered pharmacists only. By participating in the Program, you agree to abide by these terms and conditions.
  • Membership: Membership in the Program is free and requires registration. Only registered pharmacists are eligible to become members.
  • Earning Naira: Members can earn Naira by purchasing qualifying products from MeCure Industries PLC, scanning the QR codes to help propagate and promote Track & Trace, attending specified events, or engaging in other activities as outlined by the Program.
  • Promotion of Track and Trace: The Program is an initiative to promote and propagate Track and Trace practices within the pharmaceutical industry and help eliminate counterfeit medicines.
  • Program Changes: MeCure Industries PLC reserves the right to modify, suspend, or terminate the Program, or any aspect of it, at any time without prior notice.
  • Privacy: By participating in the Program, you consent to the collection and use of your personal information in accordance with MeCure Industries PLC's Privacy Policy.
  • Compliance: Members are required to comply with all applicable laws and regulations while participating in the Program.
  • Limitation of Liability: MeCure Industries PLC shall not be liable for any loss, damage, or injury arising from or related to the Program, including but not limited to, the redemption of Naira or participation in Program activities.
  • Governing Law: These terms and conditions shall be governed by and construed in accordance with the laws of Nigeria, without regard to its conflict of law principles.
  • Contact: For questions or concerns regarding the Program, please contact info@mecure.com

By participating in the MeCure Industries PLC Pharmacist Loyalty Program, you acknowledge that you have read, understood, and agree to these terms and conditions.

What Drives Us

MeCure is a leading human therapeutics company in the pharmaceutical industry in Lagos, Nigeria. For more than a decade, the company has tapped the power of new technology and innovation to advance the practice of medicine.

MeCure pioneered the development of novel products based on advances in technology and launched the pharmaceutical industry’s first tablet in a capsule formulation called Liquitab Floatcap. Today, as a leading healthcare company serving millions of patients, MeCure continues to be an entrepreneurial, technology‐driven enterprise dedicated to helping people fight everyday illness.

Our manufacturing network is continuously optimized so that our customers can have full confidence in our supply chain. This is enabled by high-volume, technologically-advanced distribution facilities. These facilities allow us to deliver new products swiftly and reliably. We continually review our capabilities and capacity. This ensures that we can consistently deliver best-in-class products. Our customers know that their end-consumers are receiving high-quality healthcare and wellness pharmaceuticals.

The core and success of our continuous drive for excellence is expressed in the values of our global team. Their commitment and sense of responsibility are derived from the awareness that every product that we make will affect another person’s health. And health is the cornerstone of our dedication to making life better.

MeCure, is committed to supporting initiatives that improve the communities where we operate, provide better access to care for patients, and improve patient outcomes by supporting research that will advance scientific knowledge about our products to generate new medical interventions.

MeCure's Quality Control (QC) team ensures the delivery of high standard products by conducting step by step review. QC, as a centre of excellence, ensures compliance and follows systematic interventions like streamlining SOPs around critical quality parameters, bullet-proofing complex procedures and targeted capacity building.

We believe in

  • Innovation, by the introduction of new ideas, methods, & invention.
  • Integrity by being honest and by always having high moral & principles.
  • Accountability by being responsible for the effects of your actions, and being willing to explain or be criticized for them.

Every single product that rolls out of our factories has our guarantee of world-class quality.

Our Mission

"To contribute to the enrichment of quality of life around Nigeria, through the creation of innovative generic and specialty pharmaceutical drugs and innovative delivery systems."

Our Vision

"Enriching Lives through Innovation in Pharmaceuticals"


We are committed to increasing access to high quality healthcare for people across Nigeria, at every stage of life. We do this by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals.

OTC Medicines

MeCure's OTC business provides branded products that are intended to prevent illness and promote well-being. These products are part of the increasing shift from treatment to prevention among consumers. This movement is a reflection of people living longer lives, while at the same time expecting continued high quality of life.

Branded Generics

MeCure’s exceptional integration of generics enables us to generate a robust pipeline of high-value medicines, with an emphasis on branded generics. Our capabilities have expanded to include tablets, capsules, liquids.

Dietary Supplements

Our superior level of nutraceutical experience is our core competence. We use state-of-the-art manufacturing methods and technology to produce products that exceed expectations, and we leverage that experience to offer our customers the highest quality solutions.

Our Achievements


Incorporated as a private limited liability company in Nigeria


Introduced Tropical Pack as the first local producer in Nigeria


Diversified into manufacturing Dry Syrup and medications of Oral Liquid


Introduction of Unit Dosage System from Sarong, Italy


Became one of the largest manufacturers of formulation of Ampicillin Cloxacillin locally and globally


In house product development of 200+ prescription chronic & acute medications


Introduction of Youthberry. Marketed HelloDoc App – a community recognising and promoting the welfare of doctors in Nigeria


ISO 9001:2015 accreditation in process


Samir Udani

Chairman Founder, MeCure. 35 years industry experience. B.Sc, Chemistry & Physics, Food Science, from Mumbai University and University Institute of Chemical Technology respectively. Healthcare Business Man of the Year in Nigeria, 2009

Arjun Udani

Co-CEO (Finance and Accounts, Logistics, Procurement and Stores) 12 years industry experience. Ex General Manager, Renaissance Life Science, Mumbai. B.sc, Business Management, Mumbai University, India. Advanced Project Management, Stanford University, California

Dukor Anderline

Co-CEO (Regulatory Affairs, Manufacturing, Quality Control & Assurance and Human Resources) Superintendent Pharmacist, Chief Regulatory Officer, MeCure. Ex Regulatory Affairs Officer, Renaissance Pharmaceuticals. 23 years pharmaceutical experience. MSc, Clinical Pharmacy, University of Lagos, 2015. B.Pharm, Pharmacy, University of Nigeria, 1992

Ayotunde Owoigbe

Partner, Banwo&Ighodalo (Independent Director) Chairman, Capital Market Solicitors Association. 19 years legal experience LLB, University of Lagos, 2000. Member, Nigerian Bar Association, 2001

Chidi Okoro

Independent Director Previously worked as a senior executive with Emzor and Glaxosmithkline Nigeria Plc (CEO) 30 years’ experience across sales and pharmaceuticals Masters, IE Business School MBA, Marketing, University of Lagos B.Pharm Pharmacy, University of Nigeria

Dr. Ajie Obi

Executive Director Lead, Pharmacovigilance Officer, MeCure.B.Sc, Medicine & Surgery (MBBS) from University of Nigeria, Enugu Campus. Masters in Pharmacology from University of Lagos. Previously worked as lecturer at Lagos State University (LUTH)

Anaje Felix Emeka

Director Sales & Marketing (Executive) B.Sc, Biochemistry, NnamdiAzikiwe University Masters, Business Administration, Ladoke Akintola University Experienced across: Sales and Marketing


Non-Executive Director B.Sc. & M.Sc. Biochemistry, M. Sc. Pharmaceutical Chemistry, Masters International Law & Diplomacy, Ph.D. Biochemistry, Forensic DNA analysis(Sorenson Forensics, Utah, USA) Advance DNA analysis (United States Federal Bureau of Investigation (FBI) in Quantico, Maryland, USA)

Executive Team

Arjun Udani

Co-CEO (Finance and Accounts, Logistics, Procurement and Stores) 12 years industry experience. Ex General Manager, Renaissance Life Science, Mumbai. B.sc, Business Management, Mumbai University, India. Advanced Project Management, Stanford University, California

Dukor Anderline

Co-CEO (Regulatory Affairs, Manufacturing, Quality Control & Assurance and Human Resources) Superintendent Pharmacist, Chief Regulatory Officer, MeCure. Ex Regulatory Affairs Officer, Renaissance Pharmaceuticals. 23 years pharmaceutical experience. MSc, Clinical Pharmacy, University of Lagos, 2015. B.Pharm, Pharmacy, University of Nigeria, 1992

Ifedamola F. Oluwasegun

CFO/Senior Vice President, Finance Ifedamola holds an MSc in Finance, Accounting, and Management from Bradford School of Management, UK. With 13 years of experience across Commercial Banking, Trade Finance, E-commerce, and Investment Banking, he began his career at Guaranty Trust Bank Plc and later served as a Trade Finance Officer at Access Bank Plc. He also co-founded and served as Head of Business Strategy and Development in an e-commerce firm (Nokkubo.com). Before joining MeCure Industries, Ifedamola was the Head of Financial Advisory/Investment Banking at Platform Capital Investment Partners. In this role, he leveraged his expertise in capital raising (debt, equity, or mezzanine), M&A advisory, and post-investment portfolio management. Additionally, he is an alumnus of the prestigious Lagos Business School, having completed the Chief Executive Program course.

Nitesh Gupta

Chief Operating Officer Former plant manager at Purna Pharmaceutical Limited. Has 27 years of pharmaceutical manufacturing experience. B.Sc, Pharmaceutical sciences MSc, Pharmaceutical sciences. Experienced across: Pharmacy, Manufacturing, Business and Operations management

Anaje Felix Emeka

Director Sales & Marketing (Executive) B.Sc, Biochemistry, NnamdiAzikiwe University Masters, Business Administration, Ladoke Akintola University Experienced across: Sales and Marketing

Sameep More

Chief Technology Officer Responsible of infrastructure & efficient running of IT operations. Over 12 years experience in leading design and development of large-scale software solutions. B.Eng, Mumbai University, India, 2007. Experienced across: Solutions design and development

Bhanubhai Patel

Chief Quality Control Officer Over 44 years of experience in quality control in the pharmaceutical industry. Former General Manager/ Assistant Technical Manager at Konark Research Foundation. B.Sc, Chemistry, South Gujarat University. A member of the Indian Pharmaceutical Association. Experienced across: Quality control and assurance

Kemi Ipinnaye

Head, Human Resource Group A graduate of English and Literature and a professional fellow of the Chartered Institute of Personnel Management (CIPM). Over 10 years experience in strategic human resourse management, business process re-engineering, strategy formulation and execution and business growth.

Shailesh Darji

Chief Accounting Officer Bachelors of Accounting & Finance (BAF), University of Bombay. Member of the Indian Accounting Association. Over 30 years of experience in accounting and analytics. Extensive business experience and strategic knowledge in the pharmaceutical space

Manufacturing and Distribution Strategy

Existing manufacturing facility, located in Oshodi Lagos, is space and capacity constrained with no room for further growth. The plant is c.100,000 sq ft

Be a part of the success story

We are looking for employees whose backgrounds and skill sets are as diverse as the brands that we nurture and grow.

Along with a fast-paced, informal work environment, MeCure offers a competitive compensation and benefits package.

MeCure is an Equal Employment Opportunity/Affirmative Action employer. We affirm the right of every person to participate in all aspects of employment without regard to race, color, religion, national origin, age, disability, creed, gender, marital status, sexual orientation, or status with regard to public assistance, or other protected classifications.

We foster team work and seek individuals that are creative and dedicated to our corporate philosophy. Twelve years of product development, dedication and innovation; support the entrepreneurial work, we pride at MeCure.


What is a Listing by Introduction?

A Listing by Introduction means that all the issued and fully paid-up shares of Me Cure Industries Plc (‘the Company’’ or ‘MeCure Industries’) will be listed on the Standard Segment of the Growth Board of NGX Exchange without any additional shares being issued. From this point, all MeCure Industries’ shareholders will be able to trade their shares on the Growth Board of NGX Exchange and members of the public can purchase shares in the Company.

How can I find more information about the Listing by Introduction?

Information about the Listing by Introduction can be found on the investor relations section of the MeCure Industries website Click here for more...

Are new shares being issued by MeCure Industries?

No. MeCure Industries is neither issuing new shares nor raising additional capital. The existing shares are only being listed and made available for trading.

How was the listing price determined?

Prior to the Listing by Introduction, there was no public trading market for the ordinary shares of the Company. A valuation analysis and a pricing memorandum were prepared by our financial advisers to provide guidance for the listing price.

Is there a listing approval procedure for the Listing by Introduction?

Yes. The listing approval procedures for a Listing by Introduction are the same as those for Initial Public Offerings and it can be found on the website of the NGX; here.

Is MeCure Industries Plc a public company?

Yes. MeCure Industries Plc (previously called MeCure Industries Limited) was incorporated on March 16, 2005 and became a public company on October 27, 2022.

Does MeCure Industries Plc intend to undertake a share offer in the future?

The Board of MeCure will consider all financing options in line with its strategic objectives and when market conditions are conducive.

How can I find out the price of MeCure’s shares?

You can find out the share price on the Company’s website (www.mecure.com) and daily equity pricelist from stockbrokers.

When can we invest in shares of MeCure Industries?

Once the shares are listed on the standard segment of the Growth Board of NGX Exchange, existing shareholders can trade their shares and prospective investors can buy.

What is the ticker symbol for MeCure Industries Plc on the Growth Board of NGX Exchange?

The Company’s symbol ticker is MECURE.

Do you have a dividend policy and what does it entail?

Payment of dividends is dependent on several key factors, including our future strategic plans and capital expenditure initiatives. The Company will share a dividend policy when available.

Who is MeCure Industries Registrar?

Cordros Registrar provides registrar services to MeCure Industries Plc.

Is Cordros regulated by an independent body?

Cordros is licensed and monitored by the Securities and Exchange Commission (SEC). If you have any enquiries regarding your MeCure share records or future corporate actions, please send an email to [insert email of registrar] and the Registrar will address your concerns accordingly.

Buying, Selling or Transferring Shares

What is a share?

A share represents part ownership in a company. A shareholder of a public company may enjoy dividends from the company’s profits, participate in its share price performance, and have the right to vote at its shareholder meetings.

As a shareholder, you are one of the owners of the company and the number of shares you hold, in proportion to the total number of the Company’s issued shares, is a measure of how much of the company you own.

How do I buy or sell shares?

You can buy or sell shares of MeCure Industries Plc through the service of a stockbroker.

I have bought/sold shares recently but there is no change to my CSCS account

It takes three days for shares traded on the floor of the NGX Exchange to be settled. If you have bought or sold shares through a stockbroker, this triggers a process at CSCS, to ensure a successful delivery of your shares. On the third day after the trade was done [T+3], CSCS will send instructions to the Registrar to amend their records. This is the date on which shares and money are exchanged in the market and is known as the ‘settlement date’. If there is still no change to your CSCS account after this day, please contact your Stockbroker for further assistance.

MeCure Industries Lists on NGX’s Growth Exchange.

Lagos, Nigeria - 08 November 2023 – MeCure Industries Plc (“MeCure Industries” or the “Company”) is pleased to announce the successful listing of its shares on the Growth Board of The Nigerian Exchange Limited (“NGX” or “The Exchange”). MeCure Industries is a pharmaceutical company with a track record of enhancing service and product delivery across the pharmaceutical and healthcare industry value chain.

MeCure Industries has satisfied the listing requirements of the Nigerian Exchange Limited and obtained all relevant regulatory approvals. We are now listed in the pharmaceutical sector of the Exchange, with the ticker “MECURE”. A total of 4,000,000,000 (Four Billion) ordinary shares were admitted to trading, representing the total issued share capital of the Company, with one of the largest market capitalisation on the Standard Segment of the NGX’s Growth Board.

Commenting on the listing, the Chairman and Founder, Mr Samir Udani said "The approval to list on the Growth Board of the Nigerian Exchange Limited marks a significant milestone in the journey to achieving our strategic expansion goals and healthy contribution to the national economy through continued reduction of the nation's dependency on import as the primary medium of access to pharmaceutical products."

“By listing on the Nigerian Exchange Limited, we will gain more visibility and expand our reach, thus attracting new investors and strengthening relationships with existing ones," said Mrs Anderline Dukor, Co-CEO of MeCure. "In addition to delivering value to shareholders, we are excited about the opportunities ahead."

Mr Arjun Udani, Co-CEO of MeCure Industries, also added, "The listing marks a new beginning for us as a Company; as it resonates with our commitment to saving lives through innovation and enhancing the health of our consumers by delivering high-quality products, while we maintain sustainable growth of the Company”.


Investors and Analysts

Ifedamola Oluwasegun
Chief Financial officer

Investor Relations Advisers
Værdi Investor Relations
Oluyemisi Lanre-Phillips

About MeCure Industries Plc

MeCure Industries is a company principally in the business of manufacturing drugs in Nigeria under two categories namely pharmaceuticals and nutraceuticals. In the pursuit of its primary objective, it adopts the use of modern-day technology and expertise care in services to restore health and save lives through its diverse solutions.

For over a decade, MeCure has developed a reputation for quality and is trusted by its stakeholders (customers, distributors, suppliers, shareholders, employees, etc.). Growth has been demonstrated through historical revenue and market share growth, backed by an experienced management team with over 150 years’ experience across multiple disciplines with a deep understanding of the pharmaceutical industry.

Download PDF

MeCure Industries Plc — Track and Trace Solution Press Release



MeCure Industries Plc Unveils Ground breaking Smartphone Track & Trace Solution, Fortifying the Pharmaceutical Supply Chain and Elevating Patient Safety Standards

Lagos, Nigeria — 8th January 2024 — MeCure Industries Plc is pleased to announce the official implementation of its Track & Trace solution, a program with cutting edge technology ensuring product safety for our customers.

Given the current pharmaceutical governance landscape, the industry faces a dual imperative: ensuring the accessibility of life-saving medications while mitigating potential threats such as falsification. The Track & Trace solution emerges as a pivotal solution, playing a critical role in preventing the infiltration of counterfeit drugs into the healthcare supply chain.

These counterfeit drugs pose a profound risk to public health in the form of incorrect ingredients, improper dosages, or deleterious substances. The ramifications of consuming such falsified medicines span from therapeutic inefficacy to life-threatening complications. Through the comprehensive implementation of a Track & Trace Solution, every stage of a drug's trajectory becomes traceable and verifiable. MeCure Track & Trace enabled brands are impossible to counterfeit.

At its essence, Track & Trace Solution entails the meticulous monitoring and documentation of the complete journey of a pharmaceutical product, commencing from its manufacturing facility to the ultimate recipient. This transparency facilitates the prompt identification of potential issues or discrepancies, thereby enabling timely corrective actions. Any suspicious deviation in the supply chain or an unauthorized alteration of product information can be flagged by the Track & Trace program for the stakeholders to intervene expeditiously, curtailing the dissemination of counterfeit drugs and safeguarding unsuspecting consumers. This amplifies the efficiency of supply chain management and, more importantly, establishes a formidable deterrent against the falsification of medicines. It is poised to serve as a beacon for
public health, guaranteeing that patients receive authentic, life-saving treatments.

Track & Trace Solution also enhances collaboration among diverse stakeholders in the pharmaceutical supply chain, including manufacturers, distributors, and regulatory bodies. Shared access to a standardized, traceable data system enhances communication and cooperation, creating a unified front against the menace of falsified medicines.

MeCure, a prominent Nigerian pharmaceutical manufacturer in collaboration with ACG Inspection, a globally recognized Track & Trace Solution provider, has demonstrated unwavering commitment to the regulator by elevating industry standards on patient safety through offering authentication of each product with just a click on any smartphone. MeCure Industries Plc — Track and Trace Solution Press Release

18 brands within the MeCure portfolio are currently Track & Trace enabled, and all of its 50+ brands will be traceable by the end of the first quarter of 2024.

MeCure Industries PLC extends its sincere appreciation to the Director General of NAFDAC, Prof. Moji Christianah Adeyeye, for her visionary leadership in consistently staying at the forefront of innovative Solutions such as Track & Trace. Her dedication reflects a profound commitment to advancing better and safer healthcare standards in Nigeria.


Investors and Analysts

Ifedamola Oluwasegun
Chief Financial officer

Investor Relations Advisers
Værdi Investor Relations
Oluyemisi Lanre-Phillips

MeCure Industries Track & Trace Solution FAQs

What is Track & Trace technology?

Track & Trace in healthcare logistics is the practice of monitoring and tracing the movement of pharmaceutical products throughout the supply chain. This system ensures real-time/ near real-time visibility, enabling efficient regulatory compliance, and rapid response to recalls. Serialization, a pivotal process in healthcare logistics, involves tagging each product with a unique 12-digit serial number. This unique identifier is printed on the product's packaging, forming the basis for precise tracking and tracing throughout the supply chain.

How will Nigeria and its stakeholders benefit?

NAFDAC and GS1 Nigeria are playing a pivotal role to encourage local manufacturers implement Track & Trace program with guidelines/regulations. Their objective is to facilitate the harmonization of critical tracking events and key data elements across the different supply chain entities thus enabling a more transparent healthcare supply chain. The heightened transparency not only aligns with regulatory requirements but also cultivates increased patient trust in the healthcare system.

What are the other benefits of the Track & Trace Solution?

In addition to enhancing supply chain visibility and ensuring product authenticity, the Track & Trace solution also reduces the risk of errors, improves inventory management, and helps in compliance with regulatory requirements while enabling quicker responses to issues such as recalls.

Where has this been implemented in Africa?

Numerous African nations, such as Ghana, South Africa, Uganda, Zambia, and Botswana, are actively working on drafting their traceability strategies and implementing regulatory guidelines to streamline and harmonize their healthcare supply chains.

How is this a solution to fight counterfeiting pharmaceutical drugs?

The global standards followed by this regulation will harmonize data exchange across the different supply chain actors, thus increasing supply chain visibility. This, in turn, reduces the susceptibility of the Nigerian pharma supply chain ecosystem to counterfeit drugs.

How does the solution handle recall or product withdrawals?

In the event of a recall or product withdrawal, the Track & Trace solution allows for rapid identification and isolation of affected items. This helps to minimize the impact on consumers and ensures regulatory compliance.

How is this helpful for pharmacovigilance and post-marketing surveillance?

Track & Trace and serialization are extremely crucial for post-marketing surveillance and pharmacovigilance activities. They help in efficient and precise recall management of affected batches, thus making the Nigerian healthcare landscape nimble in responding to and reporting adverse events and product quality issues, mitigating patient risks in the process.

How does the solution ensure data security and integrity?

The solution has been implemented with robust security measures, including encryption, authentication, and access controls, to ensure the security and integrity of the tracked data. To reinforce this, periodic audits and compliance checks will be conducted to maintain data quality.

MeCure's role in spearheading Track & Trace?

MeCure, a leading Nigerian pharmaceutical manufacturer, demonstrated its ongoing commitment to NAFDAC, by compliance towards patient safety and enhancing industry standards in the Nigerian pharmaceutical landscape by releasing Track & Trace enabled brands into the market that can be authenticated by a smartphone.

How can I access the Track & Trace information for a product I purchased?

You can access the Track & Trace information by scanning the unique code provided on the product packaging using the designated mobile application by following the prompted steps on your phone.

What device do I require to access Track & Trace program by MeCure?

All you need is a smartphone.

What information will I be able to see through the Track & Trace solution by MeCure?

The Track & Trace solution provides information on the pack origination and the quality report of the batch. It also encourages you to share any feedback on the product and adverse effects, if any, directly to the manufacturer.

Can I access the Track & Trace system before purchasing a product to verify its authenticity?

Yes, you can! We advise the use of the Track & Trace solution to verify the authenticity of product before purchase.

Do I need to register or create an account to use the Track & Trace solution as a consumer?

Registration is not mandatory for basic access.


We are thrilled to announce a significant milestone in our journey towards excellence and innovation. MeCure Industries Plc proudly welcomes the renowned and esteemed actress, Kate Henshaw, as our brand ambassador.

Kate Henshaw embodies the values of integrity, passion, and dedication, which resonate deeply with our commitment to delivering high-quality healthcare solutions to communities across Nigeria. With her illustrious career spanning decades and her unwavering commitment to social causes, Kate epitomizes the essence of authenticity and credibility, making her the perfect representative for MeCure Industries Plc.

As a brand ambassador, Kate will play a pivotal role in promoting our mission to enhance healthcare access and improve lives. Her influence and reach will help amplify our message, driving awareness of our innovative products and services while fostering trust and confidence among our customers and stakeholders.

We are confident that Kate Henshaw's association with MeCure Industries Plc will further strengthen our brand presence and reinforce our position as a leader in the pharmaceutical and healthcare industry. Together, we will embark on an exciting journey of collaboration and empowerment, making a meaningful impact on the health and well-being of Nigerians.